targeting Primitive chronic Myeloid leukemia cells by effective inhibition of a New AHi-1–Bcr-ABl–JAK2 complex

M Chen, P Gallipoli, D DeGeer, I Sloma… - Journal of the …, 2013 - academic.oup.com
Background Imatinib mesylate (IM) induces clinical remission of chronic myeloid leukemia
(CML). The Abelson helper integration site 1 (AHI-1) oncoprotein interacts with BCR-ABL …
被引用次数：109 相关文章
[PDF] semanticscholar.org

[PDF][PDF] targeting Primitive chronic Myeloid leukemia cells by effective inhibition of a New AHi-1–Bcr-ABl–JAK2 complex

M Chen, P Gallipoli, D DeGeer, I Sloma… - J Natl Cancer …, 2013 - pdfs.semanticscholar.org
Background Imatinib mesylate (IM) induces clinical remission of chronic myeloid leukemia
(CML). The Abelson helper integration site 1 (AHI-1) oncoprotein interacts with BCR-ABL …

Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex

M Chen, P Gallipoli, D DeGeer… - Journal of the …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Imatinib mesylate (IM) induces clinical remission of chronic myeloid leukemia
(CML). The Abelson helper integration site 1 (AHI-1) oncoprotein interacts with BCR-ABL …
[PDF] core.ac.uk

[PDF][PDF] targeting Primitive chronic Myeloid leukemia cells by effective inhibition of a New AHi-1–Bcr-ABl–JAK2 complex

M Chen, P Gallipoli, D DeGeer, I Sloma, DL Forrest… - J Natl Cancer …, 2013 - core.ac.uk
Background Imatinib mesylate (IM) induces clinical remission of chronic myeloid leukemia
(CML). The Abelson helper integration site 1 (AHI-1) oncoprotein interacts with BCR-ABL …
[PDF] academia.edu

[PDF][PDF] Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1–BCR-ABL–JAK2 Complex

M Chen, P Gallipoli, D DeGeer, I Sloma, DL Forrest… - 2013 - academia.edu
Background Imatinib mesylate (IM) induces clinical remission of chronic myeloid leukemia
(CML). The Abelson helper integration site 1 (AHI-1) oncoprotein interacts with BCR-ABL …

Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex

M Chen, P Gallipoli, D DeGeer, I Sloma… - Journal of the …, 2013 - eprints.gla.ac.uk
Background: Imatinib mesylate (IM) induces clinical remission of chronic myeloid leukemia
(CML). The Abelson helper integration site 1 (AHI-1) oncoprotein interacts with BCR-ABL …
[HTML] nih.gov

[HTML][HTML] Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1–BCR-ABL–JAK2 Complex

M Chen, P Gallipoli, D DeGeer, I Sloma… - JNCI Journal of the …, 2013 - ncbi.nlm.nih.gov
Background Imatinib mesylate (IM) induces clinical remission of chronic myeloid leukemia
(CML). The Abelson helper integration site 1 (AHI-1) oncoprotein interacts with BCR-ABL …

[引用][C] Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1―BCR-ABL―JAK2 Complex

MIN CHEN, P GALLIPOLI, K LAMBIE… - Journal of the …, 2013 - pascal-francis.inist.fr
Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1―BCR-ABL―JAK2
Complex CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
[PDF] qmul.ac.uk

[PDF][PDF] Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1BCR-ABL-JAK2 Complex

M Chen, P Gallipoli, D DeGeer, I Sloma… - JNCI-JOURNAL OF …, 2013 - qmro.qmul.ac.uk
Background Imatinib mesylate (IM) induces clinical remission of chronic myeloid leukemia
(CML). The Abelson helper integration site 1 (AHI-1) oncoprotein interacts with BCR-ABL …

Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex.

M Chen, P Gallipoli, D DeGeer, I Sloma… - Journal of the …, 2013 - europepmc.org
Background Imatinib mesylate (IM) induces clinical remission of chronic myeloid leukemia
(CML). The Abelson helper integration site 1 (AHI-1) oncoprotein interacts with BCR-ABL …